Recombinant Human Serpin E1/PAI-1 Protein, CF

Catalog #: 1786-PI
10 Citations 1 Review Datasheet

Catalog #	Availability	Size / Price	Qty
1786-PI-010

Recombinant Human Serpin E1/PAI-1 Protein Enzyme Activity

1 Image

All Serpin E1/PAI-1 Proteins and Enzymes

Product Details

Citations (10)

FAQs

Supplemental Products

Reviews (1)

Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Human Serpin E1/PAI-1 Protein, CF Summary

Product Specifications

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

Activity

Measured by its ability to inhibit uPA cleavage of a peptide substrate, N-carbobenzyloxy-Gly-Gly-Arg-7-amido-4-methylcoumarin (Z-GGR-AMC). The IC₅₀ value is <13 nM, as measured under the described conditions.

Source

Spodoptera frugiperda, Sf 21 (stably transfected)-derived human Serpin E1/PAI-1 protein
Met1-Pro402, with a C-terminal 10-His tag

Accession #

P05121

N-terminal Sequence
Analysis

Ser22 & Val24

Predicted Molecular Mass

44 kDa

SDS-PAGE

43 kDa, reducing conditions

Product Datasheets

1786-PI

Product Datasheet

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

1786-PI

Formulation	Lyophilized from a 0.2 μm filtered solution in Sodium Acetate, NaCl and CHAPS.
Reconstitution	Reconstitute at 500 μg/mL in sterile 50 mM Sodium Acetate and 100 mM NaCl, pH 5.5.
Shipping	The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Assay Procedure

Materials

Assay Buffer: 50 mM Tris, 0.01% (v/v) Tween® 20, pH 8.5
Recombinant Human Serpin E1/PAI-1 (rhSerpin E1/PAI-1) (Catalog # 1786-PI)
Recombinant Human u‑Plasminogen Activator (uPA)/Urokinase (rhuPA) (Catalog # 1310-SE)
Substrate: Z-Gly-Gly-Arg-AMC (Bachem, Catalog # I-1140)
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent

Dilute rhuPA to 2 µg/mL in Assay Buffer.
Prepare a rhSerpin E1/PAI-1 (MW: 44146 Da) dilution curve in Assay Buffer. Make the following serial dilutions: 1500, 750, 375, 187.5, 125, 75, 50, 25, and 12.5 nM.
Mix equal volumes of the rhSerpin E1/PAI-1 curve and the diluted rhuPA at 2 µg/mL. Include 2 controls containing rhuPA and Assay Buffer only.
Incubate mixtures at room temperature for 15 minutes.
After incubation, dilute the mixtures 5 fold in Assay Buffer.
Dilute the Substrate to 200 µM in Assay Buffer.
Load 50 µL of the incubated reactions into a plate, and start the reaction by adding 50 µL of 200 µM Substrate to each well.
Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
Determine the 50% inhibiting concentration (IC₅₀) for rhSerpin E1 by plotting RFU/min (or specific activity) vs. concentration with 4‑PL fitting.
The specific activity for rhuPA at each point may be determined using the following formula (if necessary):

Specific Activity (pmol/min/µg) =	Adjusted V_max* (RFU/min) x Conversion Factor** (pmol/RFU)
	amount of enzyme (µg)

*Adjusted for Substrate Blank
**Derived using calibration standard 7-amino, 4-Methyl Coumarin (AMC) (Sigma, Catalog # A-9891).

Per Well:

rhuPA: 0.010 µg
rhSerpin E1/PAI-1 curve: 75, 37.5, 18.75, 9.375, 6.25, 3.75, 2.5, 1.25, and 0.625 nM
Substrate: 100 µM

Scientific Data

Enzyme Activity

View Larger

Recombinant Human Serpin E1/PAI-1 (Catalog # 1786-PI) is measured by its ability to inhibit uPA cleavage of a peptide substrate, N-carbobenzyloxy-Gly-Gly-Arg-7-amido-4-methylcoumarin (Z-GGR-AMC).

Background: Serpin E1/PAI-1

As a member of the Serpin superfamily of serine protease inhibitors, Serpin E1/PAI‑1 is the principal inhibitor of urokinase‑type plasminogen activator (uPA) and tissue‑type PA (1, 2). As important regulators of extracellular matrix remodeling, uPA and PAI‑1 play a major role in many processes such as angiogenesis, tumor invasion and obesity (2‑4). For example, uPA and PAI-1 are the only tumor prognostic factors validated at the highest level of evidence with regard to their clinical utility in breast cancer (5). The human PAI-1 is initially synthesized as 402 amino acid precursor with a N‑terminal signal peptide (6, 7). PAI‑1 may exist in one of two possible conformations, designated as active or latent (8). The purified rhPAI‑1 is active against rhuPA. The heterogeneity at the N‑terminus of the purified
rhPAI‑1 has been observed before for both the recombinant and native proteins (9).

References

Silverman, G.A. et al. (2001) J. Biol. Chem. 276:33293.
Stefansson, S. et al. (2003) Curr. Pharm. Des. 9:1545.
Duffy, M.J. (2002) Clin. Chem. 48:1194.
Juhan-Vague, I. et al. (2003) J. Thromb. Haemost. 1:1575.
Harbeck, N. et al. (2002) Clin. Breast Cancer 3:196.
Pannekoek, H. et al. (1986) EMBO J. 5:2539.
Ginsburg, D. et al. (1986) J. Clin. Invest. 78:1673.
Wang, Z. et al. (1996) Biochemistry 35:16443.
Stromqvist, M. et al. (1994) Protein Expr. Purif. 5:309.

Long Name

Plasminogen Activator Inhibitor

Entrez Gene IDs

5054 (Human); 18787 (Mouse)

Alternate Names

Endothelial plasminogen activator inhibitor; Nexin; PAI1; PAI-1; PAI1PAI-1; PAISerpin E1; PLANH1; PLANH1plasminogen activator inhibitor 1; serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogenactivator inhibitor type 1), member 1; Serpin E1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitortype 1), member 1

Related Research Areas

Citations for Recombinant Human Serpin E1/PAI-1 Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

10 Citations: Showing 1 - 10
Filter your results:

Filter by:

PAI-1 uncouples integrin-?1 from restrain by membrane-bound ?-catenin to promote collagen fibril remodeling in obesity-related neoplasms
Authors: Lin, LL;Nayak, B;Osmulski, PA;Wang, E;Wang, CP;Valente, PT;Wang, CM;Tan, X;Santanam, N;Wang, TL;Gaczynska, ME;Kost, ER;Huang, TH;Kirma, NB;
Cell reports
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: Western Blot, Immunocytochemistry
Secretome analysis of in vitro aged human mesenchymal stem cells reveals IGFBP7 as a putative factor for promoting osteogenesis
Authors: A Infante, CI Rodríguez
Sci Rep, 2018-03-15;8(1):4632.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases
Cell Death Dis, 2016-12-29;7(12):e2565.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode.
Authors: Doni A, Musso T, Morone D, Bastone A, Zambelli V, Sironi M, Castagnoli C, Cambieri I, Stravalaci M, Pasqualini F, Laface I, Valentino S, Tartari S, Ponzetta A, Maina V, Barbieri S, Tremoli E, Catapano A, Norata G, Bottazzi B, Garlanda C, Mantovani A
J Exp Med, 2015-05-11;212(6):905-25.
Applications: Bioassay
Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFbeta signaling.
Authors: Santhekadur P, Akiel M, Emdad L, Gredler R, Srivastava J, Rajasekaran D, Robertson C, Mukhopadhyay N, Fisher P, Sarkar D
FEBS Open Bio, 2014-04-01;4(0):353-61.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
Regulated proteolytic processing of Reelin through interplay of tissue plasminogen activator (tPA), ADAMTS-4, ADAMTS-5, and their modulators.
Authors: Krstic D, Rodriguez M, Knuesel I
PLoS ONE, 2012-10-17;7(10):e47793.
Species: Human
Sample Types: Recombinant Protein
Applications: Enzyme Assay
A multiplex immunoassay for human adipokine profiling.
Authors: Schipper HS, De Jager W, van Dijk ME, Meerding J, Zelissen PM, Adan RA, Prakken BJ, Kalkhoven E
Clin. Chem., 2010-06-08;56(0):1320.
Applications: ELISA (Standard)
Human CD4- 8- T cells are a distinctive immunoregulatory subset.
Authors: Huang MC, Patel K, Taub DD, Longo DL, Goetzl EJ
FASEB J, 2010-02-12;24(7):2558-66.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity.
Authors: Szabo R, Hobson JP, List K, Molinolo A, Lin CY, Bugge TH
J. Biol. Chem., 2008-08-19;283(43):29495-504.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
Enzymatic properties of human kallikrein-related peptidase 12 (KLK12).
Authors: Memari</LastName><ForeNam N</Initial, Memari N, Jiang W, Diamandis EP, Luo LY
Biol. Chem., 2007-04-01;388(4):427-35.
Species: Human
Sample Types: Recombinant Protein
Applications: Enzyme Assay